By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NovoCure Ltd. 



Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Medical Device






Company News
NovoCure To Present Three Abstracts On Tumor Treating Fields And Pancreatic Cancer At The European Society For Medical Oncology 19th World Congress On Gastrointestinal Cancer 6/28/2017 10:31:05 AM
NovoCure Release: First Patient Enrolled In RTOG Trial Of Optune Together With Bevacizumab For Patients With Bevacizumab-Refractory Recurrent Glioblastoma 6/8/2017 7:07:18 AM
NovoCure Release: Health Care Service Corporation Issues Positive Coverage Decision For Optune 6/5/2017 7:30:51 AM
NovoCure Receives Humanitarian Use Device Designation For Treatment Of Pleural Mesothelioma 5/15/2017 6:08:43 AM
Martin J. Madden Joins NovoCure Board Of Directors 5/11/2017 8:23:02 AM
NovoCure Release: Combination Of Optune With Standard Of Care Chemotherapy, Temozolomide, Delayed Decline In Several Health-Related Quality Of Life Scales Compared To Temozolomide Alone For Newly Diagnosed Glioblastoma Patients 5/8/2017 6:15:26 AM
NovoCure Announces Opening Of Two Pilot Trials To Evaluate The Use Of TTFields For Pediatric Gliomas 5/4/2017 6:28:42 AM
NovoCure Reports First Quarter 2017 Financial Results And Provides Company Update 4/27/2017 5:39:43 AM
NovoCure Announces Four Presentations On Tumor Treating Fields At American Academy of Neurology Annual Meeting In Boston 4/19/2017 6:15:35 AM
NovoCure Release: CNS Oncology Publishes Data Suggesting Survival Benefit Of Optune In Combination With Second Line Chemotherapies After Glioblastoma Recurrence 4/17/2017 9:29:00 AM
12345678910...
//-->